ReviewCurrent medicinal chemistry2025

Advances in Small-molecule Dual Inhibitors Targeting EGFR and HER2 Receptors as Anti-cancer Agents.

Jia-Xiong Kang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.